Archive · 21 Nov 2025
Balaxi Pharma Stock Surges 10% Despite Market Dip
Balaxi Pharmaceuticals' stock price went up by 10% today, even though the rest of the Indian stock market was going down.
This is surprising because the stock has been going down a lot this year, and the company's profits have also been going down.
Retail investors, who are regular people who buy stocks, have lost a lot of money because they own a big part of the company's shares.
Balaxi Pharmaceuticals' stock rose 10% in intraday trade on November 21
The stock has been down 47.42% year-to-date, extending losses from previous years
Retail investors hold 30.5% of the company's shares
The company reported weak Q2 FY26 results with revenue and profit down significantly
Gross margin improved by 540 bps to 48.3% despite revenue drop
- Who
- Balaxi Pharmaceuticals
- What
- Experienced a stock price increase
- When
- November 21, 2024
- Where
- Indian stock market (Dalal Street)
- Why
- Despite broader market weakness and recent poor financial performance
Bullish View
Bearish View
Stock Performance
Bullish View
Stock price increased by 10% today
Bearish View
Stock has been down 47.42% year-to-date
Company Performance
Bullish View
Gross margin improved significantly in Q2 FY26
Bearish View
Revenue and profit down significantly in Q2 FY26
- Stock Performance (Nov 21, 2024)
- Increased by 10% to ₹39.5
- Year-to-Date Performance
- Down 47.42%
- Retail Investor Ownership
- 30.5% of shares
- Q2 FY26 Revenue
- Down 27.4% YoY to ₹56.17 crore
- Q2 FY26 Gross Margin
- Up 540 bps to 48.3%